+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
X-Ray Contrast Media Market by Product Composition (Barium Sulfate Based Media, Carbon Dioxide Contrast Media, Iodinated Contrast Media), Diagnostic Application (Angiography, Computed Tomography, Fluoroscopy), Administration Route, Patient Demographic - Global Forecast to 2030- Product Image
X-Ray Contrast Media Market by Product Composition (Barium Sulfate Based Media, Carbon Dioxide Contrast Media, Iodinated Contrast Media), Diagnostic Application (Angiography, Computed Tomography, Fluoroscopy), Administration Route, Patient Demographic - Global Forecast to 2030- Product Image
Sale

X-Ray Contrast Media Market by Product Composition (Barium Sulfate Based Media, Carbon Dioxide Contrast Media, Iodinated Contrast Media), Diagnostic Application (Angiography, Computed Tomography, Fluoroscopy), Administration Route, Patient Demographic - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6159689
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
X-ray contrast media represent a cornerstone of diagnostic imaging, empowering clinicians to visualize internal structures with exceptional clarity. Over recent years, escalating demand for minimally invasive procedures and rising prevalence of chronic diseases have intensified the need for advanced contrast agents. As a result, manufacturers have pursued formulation innovations, aiming to improve patient safety and diagnostic accuracy while addressing concerns such as adverse reactions and environmental impact.

Amidst this backdrop, the competitive landscape has dynamically evolved. Established industry leaders continue to refine iodinated and barium-based solutions, while agile newcomers introduce alternative media like carbon dioxide, targeting niche applications. At the same time, regulatory scrutiny has heightened, prompting a wave of compliance-driven reformulations and quality enhancements. Consequently, stakeholders across the value chain-from raw material suppliers to healthcare providers-must navigate a complex interplay of technological breakthroughs, policy shifts, and shifting end-user expectations.

This executive summary synthesizes critical insights into the transformative trends reshaping the X-ray contrast media market. It outlines key segmentation dynamics, dissects the cumulative impact of new United States tariffs in 2025, highlights regional and competitive benchmarks, and concludes with actionable recommendations for industry leaders seeking to secure a competitive edge.

Transformative Shifts Reshaping the X-Ray Contrast Media Market

The X-ray contrast media landscape is undergoing transformative shifts driven by technological innovation and evolving clinical needs. First, the development of low-osmolar and iso-osmolar iodinated agents has significantly reduced adverse reactions, prompting many healthcare systems to transition away from high-osmolar formulations. Meanwhile, alternative contrast options such as carbon dioxide have garnered attention for patients with renal impairment, underscoring a broader movement toward personalized imaging solutions.

Concurrently, digital imaging and artificial intelligence integration have revolutionized diagnostic workflows. Advanced imaging software now enhances contrast visualization in real time, enabling more precise lesion detection and reducing scan times. This synergy between contrast media and imaging platforms is fostering partnerships between pharmaceutical companies and medical device manufacturers, unlocking new opportunities for co-development and cross-licensing.

Regulatory landscapes have also shifted, with agencies worldwide imposing stricter guidelines on contrast agent safety and environmental disposability. Manufacturers have responded by investing in eco-friendly excipients and biodegradable packaging. Taken together, these factors are recalibrating competitive priorities, with R&D pipelines increasingly focused on multi-modal contrast agents and novel delivery mechanisms.

Assessing the Cumulative Impact of United States Tariffs in 2025

In 2025, newly enacted United States tariffs on imported raw materials and finished contrast agents have imparted a cumulative impact across the value chain. Raw material suppliers now face elevated duties on key components used in iodinated media, translating into higher production costs for blend manufacturers. This cost pressure has, in turn, been passed along to distributors and healthcare providers, squeezing margins and compelling contract renegotiations.

Moreover, the tariffs have disrupted established procurement strategies. Several contrast agent producers have begun re-evaluating their global sourcing models, shifting toward domestic or nearshore suppliers to mitigate duty exposure. This strategic realignment has prompted a surge in partnerships with regional chemical manufacturers and triggered capacity expansions in domestic formulation plants.

Despite these adjustments, smaller players without established U.S. operations have encountered significant headwinds in maintaining price competitiveness. Consequently, consolidation activity has accelerated as mid-sized firms seek alliances or mergers to absorb tariff-related cost increases. Looking ahead, stakeholders will need to adopt agile supply chain strategies-such as demand forecasting improvements and hedging practices-to stabilize operations in the face of ongoing trade policy volatility.

Key Segmentation Insights Driving Market Differentiation

Segmentation analysis reveals nuanced demand drivers across product composition, diagnostic application, administration route, and patient demographic. From a product composition standpoint, barium sulfate based media continue to dominate gastrointestinal examinations, with pre-enhanced and standard preparations catering to varied visualization requirements. Concurrently, iodinated contrast media maintain a broad footprint across vascular imaging, with high-, iso-, and low-osmolar formulations enabling tailored protocols that balance image quality with patient tolerance. Meanwhile, carbon dioxide contrast media have carved out a niche in vascular studies requiring gas-based opacification, reflecting a growing emphasis on renal safety.

Diagnostic application segmentation underscores that computed tomography and fluoroscopy remain the primary end-uses, while angiography and gastrointestinal examination grow in parallel. In angiography, coronary and peripheral procedures each demand specific agent profiles to optimize vessel delineation, whereas upper and lower gastrointestinal examinations leverage barium suspensions formulated for targeted contrast density and flow characteristics.

Administration route segmentation highlights intravenous administration as the leading delivery method, with manual and power injection variants adapting to clinical workflow preferences. Intra-arterial, oral, and rectal routes also sustain significant use cases, particularly in specialized settings where localized agent deployment enhances diagnostic precision.

Patient demographic segmentation further enriches market insights. Adult patients-divided into young adults, middle aged, and senior adults-constitute the core user base, driving broad-spectrum contrast usage. Geriatric patients, who often present with comorbidities, increasingly rely on low-risk, iso-osmolar agents, while pediatric protocols emphasize reduced dosage and tailored viscosity to address safety concerns in younger populations.

Regional Dynamics Across Major Geographies

Regional dynamics exert a profound influence on market growth trajectories. In the Americas, robust healthcare infrastructure and high adoption of advanced imaging modalities sustain demand for premium contrast agents. The focus on outpatient imaging centers and ambulatory care enhances volume, particularly for low-osmolar and iso-osmolar iodinated formulations.

In Europe, Middle East & Africa, divergent regulatory frameworks and varying reimbursement policies create a mosaic of market opportunities. Western Europe remains a mature market with steady uptake of innovative contrast solutions, while emerging economies in the Middle East and Africa exhibit rising investments in diagnostic imaging equipment, driving incremental demand for cost-effective contrast media.

Asia-Pacific stands out for its rapid expansion, fueled by rising healthcare expenditure, growing incidence of chronic diseases, and government initiatives to improve diagnostic access. Key markets such as China, India, and Southeast Asia are witnessing accelerated adoption of computed tomography and angiography procedures, prompting both expatriate and local manufacturers to expand distribution networks and form strategic joint ventures.

Competitive Landscape: Leading Companies and Innovations

The competitive landscape encompasses a spectrum of established leaders, specialized innovators, and emerging challengers. Global giants such as Bayer AG, Bracco Diagnostics Inc., GE Healthcare, Philips Healthcare, and Siemens Healthineers leverage extensive R&D budgets to advance next-generation contrast formulations and integrated imaging solutions. These companies maintain strong distribution channels and benefit from brand recognition among radiologists and healthcare institutions.

Mid-tier players-including AccuContrast Technologies, Clarion Imaging Sciences, ContrastMed Inc., DynaContrast Inc., EchoContrast Technologies, Guerbet, Imago Contrast Solutions, Innovacert Imaging, IonNext Medical, Ixen Imaging, Lumina Imaging Systems, MedContrast Laboratories, NovaContrast Inc., OptiContrast Corp, ProContrast Solutions, Radiant Contrast Technologies, RadiContrast Innovations, SpectraMed Imaging, Spectrum Imaging Solutions, VistaContrast Medical, Visualize Medical Imaging, and Xenon Imaging Solutions-focus on niche formulations, flexible contract manufacturing, and regional marketing agility. Their strategic advantages lie in specialized product portfolios, faster time-to-market for new agents, and targeted collaborations with diagnostic centers.

Additionally, certain companies such as Canon Medical Systems and Mallinckrodt Pharmaceuticals integrate imaging hardware and software innovations with contrast media expertise, fostering holistic diagnostic platforms. This convergence of device-agent synergy positions them to address evolving clinical workflows and end-user preferences effectively.

Actionable Recommendations for Industry Leaders

Industry leaders should adopt a multi-pronged strategy to navigate this dynamic environment. First, prioritizing R&D investments in low-risk, eco-friendly formulations will differentiate portfolios and meet emerging regulatory standards. Second, forging strategic alliances between contrast media producers and imaging device manufacturers can accelerate co-development of integrated diagnostics, improving clinical outcomes.

Furthermore, enhancing supply chain resilience through diversified sourcing and nearshore manufacturing will safeguard operations against trade policy disruptions such as tariffs. Implementing advanced demand forecasting tools and real-time inventory tracking can further mitigate cost volatility. In parallel, companies should strengthen relationships with key opinion leaders in radiology to validate the clinical advantages of novel agents, thereby facilitating formulary inclusion and securing reimbursement support.

Finally, expanding presence in high-growth regions-particularly Asia-Pacific-via joint ventures, distribution partnerships, and localized manufacturing will unlock new revenue streams. By combining global best practices with market-specific insights, organizations can capture share in both mature and emerging markets while sustaining long-term growth.

Conclusion: Positioning for Growth in a Evolving Landscape

As the X-ray contrast media sector continues to evolve, stakeholders must embrace innovation and adaptability. The interplay of regulatory shifts, trade policies, and technological advancements underscores the importance of proactive strategy formulation. Companies that invest in next-generation formulations, cultivate strategic partnerships, and reinforce supply chain agility will emerge as market leaders.

Moreover, understanding granular segmentation trends-from patient demographics to administration routes-enables tailored product development and marketing approaches. Simultaneously, regional insights highlight where targeted investments can yield disproportionate returns, particularly in fast-growing Asia-Pacific markets.

In conclusion, this market analysis provides a roadmap for decision-makers seeking to optimize their competitive positioning. By implementing the recommendations outlined here, organizations can not only mitigate emerging challenges but also capitalize on transformative opportunities, securing sustainable growth in an increasingly complex landscape.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Composition
    • Barium Sulfate Based Media
      • Pre Enhanced Preparation
      • Standard Preparation
    • Carbon Dioxide Contrast Media
    • Iodinated Contrast Media
      • High Osmolar
      • Iso Osmolar
      • Low Osmolar
  • Diagnostic Application
    • Angiography
      • Coronary Angiography
      • Peripheral Angiography
    • Computed Tomography
    • Fluoroscopy
    • Gastrointestinal Examination
      • Lower Gastrointestinal
      • Upper Gastrointestinal
  • Administration Route
    • Intra Arterial Administration
    • Intravenous Administration
      • Manual Injection
      • Power Injection
    • Oral Administration
    • Rectal Administration
  • Patient Demographic
    • Adult Patients
      • Middle Aged
      • Senior Adults
      • Young Adults
    • Geriatric Patients
    • Pediatric Patients
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • AccuContrast Technologies
  • Bayer AG
  • Bracco Diagnostics Inc.
  • Canon Medical Systems
  • Clarion Imaging Sciences
  • ClearView Imaging
  • ContrastMed Inc.
  • DynaContrast Inc.
  • EchoContrast Technologies
  • GE Healthcare
  • Guerbet
  • Imago Contrast Solutions
  • Innovacert Imaging
  • IonNext Medical
  • Ixen Imaging
  • Lumina Imaging Systems
  • Mallinckrodt Pharmaceuticals
  • MedContrast Laboratories
  • NovaContrast Inc.
  • OptiContrast Corp
  • Philips Healthcare
  • ProContrast Solutions
  • Radiant Contrast Technologies
  • RadiContrast Innovations
  • Siemens Healthineers
  • SpectraMed Imaging
  • Spectrum Imaging Solutions
  • VistaContrast Medical
  • Visualize Medical Imaging
  • Xenon Imaging Solutions

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. X-Ray Contrast Media Market, by Product Composition
8.1. Introduction
8.2. Barium Sulfate Based Media
8.2.1. Pre Enhanced Preparation
8.2.2. Standard Preparation
8.3. Carbon Dioxide Contrast Media
8.4. Iodinated Contrast Media
8.4.1. High Osmolar
8.4.2. Iso Osmolar
8.4.3. Low Osmolar
9. X-Ray Contrast Media Market, by Diagnostic Application
9.1. Introduction
9.2. Angiography
9.2.1. Coronary Angiography
9.2.2. Peripheral Angiography
9.3. Computed Tomography
9.4. Fluoroscopy
9.5. Gastrointestinal Examination
9.5.1. Lower Gastrointestinal
9.5.2. Upper Gastrointestinal
10. X-Ray Contrast Media Market, by Administration Route
10.1. Introduction
10.2. Intra Arterial Administration
10.3. Intravenous Administration
10.3.1. Manual Injection
10.3.2. Power Injection
10.4. Oral Administration
10.5. Rectal Administration
11. X-Ray Contrast Media Market, by Patient Demographic
11.1. Introduction
11.2. Adult Patients
11.2.1. Middle Aged
11.2.2. Senior Adults
11.2.3. Young Adults
11.3. Geriatric Patients
11.4. Pediatric Patients
12. Americas X-Ray Contrast Media Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific X-Ray Contrast Media Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa X-Ray Contrast Media Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AccuContrast Technologies
15.3.2. Bayer AG
15.3.3. Bracco Diagnostics Inc.
15.3.4. Canon Medical Systems
15.3.5. Clarion Imaging Sciences
15.3.6. ClearView Imaging
15.3.7. ContrastMed Inc.
15.3.8. DynaContrast Inc.
15.3.9. EchoContrast Technologies
15.3.10. GE Healthcare
15.3.11. Guerbet
15.3.12. Imago Contrast Solutions
15.3.13. Innovacert Imaging
15.3.14. IonNext Medical
15.3.15. Ixen Imaging
15.3.16. Lumina Imaging Systems
15.3.17. Mallinckrodt Pharmaceuticals
15.3.18. MedContrast Laboratories
15.3.19. NovaContrast Inc.
15.3.20. OptiContrast Corp
15.3.21. Philips Healthcare
15.3.22. ProContrast Solutions
15.3.23. Radiant Contrast Technologies
15.3.24. RadiContrast Innovations
15.3.25. Siemens Healthineers
15.3.26. SpectraMed Imaging
15.3.27. Spectrum Imaging Solutions
15.3.28. VistaContrast Medical
15.3.29. Visualize Medical Imaging
15.3.30. Xenon Imaging Solutions
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. X-RAY CONTRAST MEDIA MARKET MULTI-CURRENCY
FIGURE 2. X-RAY CONTRAST MEDIA MARKET MULTI-LANGUAGE
FIGURE 3. X-RAY CONTRAST MEDIA MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2024 VS 2030 (%)
FIGURE 14. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS X-RAY CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS X-RAY CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES X-RAY CONTRAST MEDIA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES X-RAY CONTRAST MEDIA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC X-RAY CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC X-RAY CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA X-RAY CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA X-RAY CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. X-RAY CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. X-RAY CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. X-RAY CONTRAST MEDIA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY PRE ENHANCED PREPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY STANDARD PREPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY CARBON DIOXIDE CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY HIGH OSMOLAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY ISO OSMOLAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY LOW OSMOLAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY CORONARY ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY PERIPHERAL ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY FLUOROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY LOWER GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY UPPER GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRA ARTERIAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY MANUAL INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY POWER INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY RECTAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY MIDDLE AGED, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY SENIOR ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY GERIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL X-RAY CONTRAST MEDIA MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS X-RAY CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 75. CANADA X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 76. CANADA X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 77. CANADA X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 78. CANADA X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. CANADA X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 80. CANADA X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 81. CANADA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 82. CANADA X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. CANADA X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 84. CANADA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 86. MEXICO X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 87. MEXICO X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 88. MEXICO X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. MEXICO X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 90. MEXICO X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 91. MEXICO X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 92. MEXICO X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. MEXICO X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 94. MEXICO X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES X-RAY CONTRAST MEDIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC X-RAY CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 126. AUSTRALIA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 127. CHINA X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 128. CHINA X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 129. CHINA X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 130. CHINA X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. CHINA X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 132. CHINA X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 133. CHINA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 134. CHINA X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. CHINA X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 136. CHINA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 137. INDIA X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 138. INDIA X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 139. INDIA X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 140. INDIA X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. INDIA X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 142. INDIA X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 143. INDIA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 144. INDIA X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. INDIA X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 146. INDIA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 154. INDONESIA X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. INDONESIA X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 156. INDONESIA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 157. JAPAN X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 158. JAPAN X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 159. JAPAN X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 160. JAPAN X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. JAPAN X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 162. JAPAN X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 163. JAPAN X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 164. JAPAN X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. JAPAN X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 166. JAPAN X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 176. MALAYSIA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 184. PHILIPPINES X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. PHILIPPINES X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 186. PHILIPPINES X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 194. SINGAPORE X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 195. SINGAPORE X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 196. SINGAPORE X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH KOREA X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 205. SOUTH KOREA X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 206. SOUTH KOREA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 207. TAIWAN X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 214. TAIWAN X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. TAIWAN X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 216. TAIWAN X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 217. THAILAND X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 218. THAILAND X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 219. THAILAND X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 220. THAILAND X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. THAILAND X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 222. THAILAND X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 223. THAILAND X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 224. THAILAND X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 225. THAILAND X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 226. THAILAND X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 234. VIETNAM X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 235. VIETNAM X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 236. VIETNAM X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA X-RAY CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 248. DENMARK X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 249. DENMARK X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 250. DENMARK X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 251. DENMARK X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. DENMARK X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 253. DENMARK X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 254. DENMARK X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 255. DENMARK X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 256. DENMARK X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 257. DENMARK X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 258. EGYPT X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 259. EGYPT X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 260. EGYPT X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 261. EGYPT X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. EGYPT X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 263. EGYPT X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 264. EGYPT X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 265. EGYPT X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 266. EGYPT X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 267. EGYPT X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 268. FINLAND X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 269. FINLAND X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 270. FINLAND X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 271. FINLAND X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. FINLAND X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 273. FINLAND X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 274. FINLAND X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 275. FINLAND X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 276. FINLAND X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 277. FINLAND X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 278. FRANCE X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 279. FRANCE X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 280. FRANCE X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 281. FRANCE X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. FRANCE X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 283. FRANCE X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 284. FRANCE X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 285. FRANCE X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 286. FRANCE X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 287. FRANCE X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 288. GERMANY X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 289. GERMANY X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 290. GERMANY X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 291. GERMANY X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. GERMANY X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 293. GERMANY X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 294. GERMANY X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 295. GERMANY X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 296. GERMANY X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 297. GERMANY X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 304. ISRAEL X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 305. ISRAEL X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 306. ISRAEL X-RAY CONTRAST MEDIA MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2030 (USD MILLION)
TABLE 307. ISRAEL X-RAY CONTRAST MEDIA MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 308. ITALY X-RAY CONTRAST MEDIA MARKET SIZE, BY PRODUCT COMPOSITION, 2018-2030 (USD MILLION)
TABLE 309. ITALY X-RAY CONTRAST MEDIA MARKET SIZE, BY BARIUM SULFATE BASED MEDIA, 2018-2030 (USD MILLION)
TABLE 310. ITALY X-RAY CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, 2018-2030 (USD MILLION)
TABLE 311. ITALY X-RAY CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. ITALY X-RAY CONTRAST MEDIA MARKET SIZE, BY ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 313. ITALY X-RAY CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 314. ITALY X-RAY CONTRAST MEDIA MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 315. ITALY X-RAY CONTRAST MEDIA MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 316. ITALY X-RAY CONTRAST MEDIA MARKET SIZE, BY PA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this X-Ray Contrast Media market report include:
  • AccuContrast Technologies
  • Bayer AG
  • Bracco Diagnostics Inc.
  • Canon Medical Systems
  • Clarion Imaging Sciences
  • ClearView Imaging
  • ContrastMed Inc.
  • DynaContrast Inc.
  • EchoContrast Technologies
  • GE Healthcare
  • Guerbet
  • Imago Contrast Solutions
  • Innovacert Imaging
  • IonNext Medical
  • Ixen Imaging
  • Lumina Imaging Systems
  • Mallinckrodt Pharmaceuticals
  • MedContrast Laboratories
  • NovaContrast Inc.
  • OptiContrast Corp
  • Philips Healthcare
  • ProContrast Solutions
  • Radiant Contrast Technologies
  • RadiContrast Innovations
  • Siemens Healthineers
  • SpectraMed Imaging
  • Spectrum Imaging Solutions
  • VistaContrast Medical
  • Visualize Medical Imaging
  • Xenon Imaging Solutions

Related Topics

Related Reports

Non-iodinated X-ray Contrast Agents Market by Product (Air, Barium Sulfate, Carbon Dioxide), Application (Angiography, Gastrointestinal Imaging), Route of Administration, End User, Formulation - Global Forecast 2025-2030 - Product Image

Non-iodinated X-ray Contrast Agents Market by Product (Air, Barium Sulfate, Carbon Dioxide), Application (Angiography, Gastrointestinal Imaging), Route of Administration, End User, Formulation - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Iodinated X-Ray Contrast Media Market by Application (Angiography, Ct Imaging, Urography), Product Type (Ionic, Non Ionic), Osmolarity, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Iodinated X-Ray Contrast Media Market by Application (Angiography, Ct Imaging, Urography), Product Type (Ionic, Non Ionic), Osmolarity, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Contrast Media Market: Analysis By Type, By Indication, By Route of Administration, By Procedure, By End User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Product Image

Contrast Media Market: Analysis By Type, By Indication, By Route of Administration, By Procedure, By End User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029

  • Report
  • 184 Pages
  • Global
From
Contrast Media/Contrast Agent Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034) - Product Image

Contrast Media/Contrast Agent Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Europe Peripheral Vascular Angiography Contrast Media Market Size, Share & Trends Analysis Report by Modality (CT/X-Ray, Ultrasound), Product (Iodinated Contrast Media, Microbubble), End Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Europe Peripheral Vascular Angiography Contrast Media Market Size, Share & Trends Analysis Report by Modality (CT/X-Ray, Ultrasound), Product (Iodinated Contrast Media, Microbubble), End Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 180 Pages
  • Europe
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.